Logo image of EVA.MI

ASKOLL EVA SPA (EVA.MI) Stock Fundamental Analysis

BIT:EVA - Euronext Milan - IT0005337123 - Common Stock - Currency: EUR

0.111  0 (-2.63%)

Fundamental Rating

1

Taking everything into account, EVA scores 1 out of 10 in our fundamental rating. EVA was compared to 32 industry peers in the Automobiles industry. EVA may be in some trouble as it scores bad on both profitability and health. EVA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year EVA has reported negative net income.
EVA had a negative operating cash flow in the past year.
EVA had negative earnings in each of the past 5 years.
EVA had a negative operating cash flow in each of the past 5 years.
EVA.MI Yearly Net Income VS EBIT VS OCF VS FCFEVA.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

The Return On Assets of EVA (-20.27%) is worse than 85.29% of its industry peers.
EVA's Return On Equity of -216.02% is on the low side compared to the rest of the industry. EVA is outperformed by 88.24% of its industry peers.
Industry RankSector Rank
ROA -20.27%
ROE -216.02%
ROIC N/A
ROA(3y)-7.41%
ROA(5y)-16.46%
ROE(3y)-23.38%
ROE(5y)-55.95%
ROIC(3y)N/A
ROIC(5y)N/A
EVA.MI Yearly ROA, ROE, ROICEVA.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -50 -100 -150

1.3 Margins

With an excellent Gross Margin value of 44.91%, EVA belongs to the best of the industry, outperforming 91.18% of the companies in the same industry.
EVA's Gross Margin has improved in the last couple of years.
EVA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5Y7.04%
EVA.MI Yearly Profit, Operating, Gross MarginsEVA.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600

1

2. Health

2.1 Basic Checks

EVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
EVA has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, EVA has more shares outstanding
Compared to 1 year ago, EVA has a worse debt to assets ratio.
EVA.MI Yearly Shares OutstandingEVA.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2020 2021 2022 2023 5M 10M 15M 20M 25M
EVA.MI Yearly Total Debt VS Total AssetsEVA.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

EVA has an Altman-Z score of -0.41. This is a bad value and indicates that EVA is not financially healthy and even has some risk of bankruptcy.
EVA has a Altman-Z score of -0.41. This is amonst the worse of the industry: EVA underperforms 85.29% of its industry peers.
EVA has a Debt/Equity ratio of 4.56. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 4.56, EVA is doing worse than 88.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.56
Debt/FCF N/A
Altman-Z -0.41
ROIC/WACCN/A
WACC7.21%
EVA.MI Yearly LT Debt VS Equity VS FCFEVA.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 1.37 indicates that EVA should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.37, EVA is doing good in the industry, outperforming 79.41% of the companies in the same industry.
A Quick Ratio of 0.81 indicates that EVA may have some problems paying its short term obligations.
With a Quick ratio value of 0.81, EVA is not doing good in the industry: 64.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.81
EVA.MI Yearly Current Assets VS Current LiabilitesEVA.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2

3. Growth

3.1 Past

The earnings per share for EVA have decreased strongly by -300.68% in the last year.
Looking at the last year, EVA shows a very negative growth in Revenue. The Revenue has decreased by -28.96% in the last year.
Measured over the past years, EVA shows a decrease in Revenue. The Revenue has been decreasing by -7.85% on average per year.
EPS 1Y (TTM)-300.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-314.5%
Revenue 1Y (TTM)-28.96%
Revenue growth 3Y-0.07%
Revenue growth 5Y-7.85%
Sales Q2Q%-26.95%

3.2 Future

EVA is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -23.61% yearly.
EVA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.82% yearly.
EPS Next Y-277.77%
EPS Next 2Y-59.86%
EPS Next 3Y-23.61%
EPS Next 5YN/A
Revenue Next Year-22.22%
Revenue Next 2Y-2.82%
Revenue Next 3Y11.82%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EVA.MI Yearly Revenue VS EstimatesEVA.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
EVA.MI Yearly EPS VS EstimatesEVA.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.1 -0.2 -0.3

0

4. Valuation

4.1 Price/Earnings Ratio

EVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EVA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EVA.MI Price Earnings VS Forward Price EarningsEVA.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EVA.MI Per share dataEVA.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2

4.3 Compensation for Growth

A cheap valuation may be justified as EVA's earnings are expected to decrease with -23.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-59.86%
EPS Next 3Y-23.61%

0

5. Dividend

5.1 Amount

EVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ASKOLL EVA SPA

BIT:EVA (3/4/2025, 7:00:00 PM)

0.111

0 (-2.63%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.22%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.83M
Analysts45.71
Price Target0.2 (80.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.12
P/FCF N/A
P/OCF N/A
P/B 2.99
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.24
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.1
BVpS0.04
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.27%
ROE -216.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.91%
FCFM N/A
ROA(3y)-7.41%
ROA(5y)-16.46%
ROE(3y)-23.38%
ROE(5y)-55.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5Y7.04%
F-Score1
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 4.56
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 43.76%
Cap/Sales 10.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 0.81
Altman-Z -0.41
F-Score1
WACC7.21%
ROIC/WACCN/A
Cap/Depr(3y)17274.4%
Cap/Depr(5y)12499.6%
Cap/Sales(3y)13.43%
Cap/Sales(5y)15.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-300.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-314.5%
EPS Next Y-277.77%
EPS Next 2Y-59.86%
EPS Next 3Y-23.61%
EPS Next 5YN/A
Revenue 1Y (TTM)-28.96%
Revenue growth 3Y-0.07%
Revenue growth 5Y-7.85%
Sales Q2Q%-26.95%
Revenue Next Year-22.22%
Revenue Next 2Y-2.82%
Revenue Next 3Y11.82%
Revenue Next 5YN/A
EBIT growth 1Y-246.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-18.52%
EBIT Next 3Y23.61%
EBIT Next 5YN/A
FCF growth 1Y64.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y74.24%
OCF growth 3YN/A
OCF growth 5YN/A